0.2625
1.35%
0.0035
Handel nachbörslich:
.26
-0.0025
-0.95%
Finanzdaten der Petros Pharmaceuticals Inc-Aktie (PTPI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
74.91%
1.3888
|
5.5347 | 0.1685 | 1.994 | 2.518 |
Cost Of Revenue |
109.82%
0.3318
|
0.1581 | 0.4085 | 0.5139 | 0.5507 |
Gross Profit |
302.33%
1.057
|
-0.5224 | 1.2662 | 1.4802 | 1.9672 |
Operating Expenses
|
10.39%
4.9852
|
4.5162 | 6.0728 | 3.943 | 3.2765 |
Benefits Costs and Expenses |
31.92%
3.5515
|
5.2165 | 4.718 | - | 3.9031 |
Costs And Expenses |
31.92%
3.5515
|
5.2165 | 4.718 | 4.4568 | 3.9031 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
22.04%
-3.9283
|
-5.0386 | -4.8066 | -2.4628 | -1.3093 |
Net Interest Income/Expense |
33.29%
0.1518
|
0.2276 | 0.1685 | -0.0529 | -0.0663 |
Interest Income/Expense After Provision For Losses |
33.29%
0.1518
|
0.2276 | 0.1685 | -0.0529 | -0.0663 |
Income/Loss From Continuing Operations Before Tax |
779.76%
-2.1627
|
0.3182 | -4.5495 | 1.994 | -1.3851 |
Income/Loss From Continuing Operations After Tax |
779.76%
-2.1627
|
0.3182 | -4.5495 | -2.5467 | -1.3851 |
Net Income/Loss
|
779.76%
-2.1627
|
0.3182 | -4.5495 | -2.5467 | -1.3851 |
Preferred Stock Dividends And Other Adjustments |
10.40%
5.8643
|
5.312 | 0.3392 | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
6,971%
4.757
|
0.0673 | 2.1196 | 2.1176 | 2.0887 |
Diluted Average Shares |
6,971%
4.757
|
0.0673 | 2.1196 | 2.1176 | 2.0887 |
Basic Earnings Per Share |
22.12%
-1.69
|
-2.17 | -2.31 | -1.20 | -0.66 |
Diluted Earnings Per Share |
22.12%
-1.69
|
-2.17 | -2.31 | -1.20 | -0.66 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
10.40%
5.8643
|
5.312 | 0.3392 | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):